Doctor profile · Federal record

Dr. Neeraj Sharma, MD

Medical Oncology Physician (CMS: Medical Oncology) · Longview, TX

  • NPI 1851334759
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 35 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1300 N 4Th St
Longview, TX 756014717
(903) 757-2122
fax (903) 757-9475
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
May 8, 2008
Year of graduation
1991 — 35 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Texas #L1459
Medicaid (2)
TX #143098501 · TX #143098503

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1851334759. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
126,783
Distinct HCPCS
10
Medicare allowed
$1,586,051
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 35,700 54 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 20,480 35 $3
J9271 Injection, pembrolizumab, 1 mg 17,300 38 $53
J9267 Injection, paclitaxel, 1 mg 10,234 26 $0
J1756 Injection, iron sucrose, 1 mg 8,900 20 $0
J9263 Injection, oxaliplatin, 0.5 mg 6,400 14 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 6,194 63 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,253 84 $0
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg 1,890 13 $29
36415 Insertion of needle into vein for collection of blood sample 1,847 436 $8

In context: peer comparison

Among 2 peers in this city , average services per provider: 1,582. This provider delivers 80× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,037
Transactions
35
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
PFIZER INC. 3 $1,234.52
Incyte Corporation 3 $155.72
E.R. Squibb & Sons, L.L.C. 5 $82.51
GlaxoSmithKline, LLC. 4 $78.83
Aveo Pharmaceuticals, Inc. 2 $77.35
ABBVIE INC. 3 $64.64
Regeneron Healthcare Solutions, Inc. 3 $62.11
Lilly USA, LLC 3 $49.27
Merck Sharp & Dohme LLC 2 $38.56
AstraZeneca Pharmaceuticals LP 2 $38.42
Bayer Healthcare Pharmaceuticals Inc. 1 $27.87
Geron Corporation 1 $25.59
Blueprint Medicines Corporation 1 $23.43
Eisai Inc. 1 $22.70
SOBI, INC 1 $22.30

By nature of payment

Honoraria
$1,200
Food and Beverage
$737
Education
$100

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,283
Patients
304
Total drug cost
$1,755,991
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 197 34 $6,818
Potassium Chloride Generic 178 87 $2,085
Letrozole Generic 159 40 $3,624
Levothyroxine Sodium Generic 113 31 $1,420
Gabapentin Generic 105 25 $1,802
Eliquis (Apixaban) Brand 84 14 $63,182
Acyclovir Generic 79 16 $1,574
Alendronate Sodium Generic 56 12 $407
Dexamethasone Generic 55 22 $738
Imbruvica (Ibrutinib) Brand 55 0 $896,995

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Neeraj Sharma's medical specialty?
Dr. Neeraj Sharma practices Medical Oncology Physician in Longview, TX.
Where does Dr. Neeraj Sharma practice?
Dr. Neeraj Sharma practices at 1300 N 4Th St, Longview, TX 756014717. Office phone: 9037572122.
What is Dr. Neeraj Sharma's NPI?
Dr. Neeraj Sharma's National Provider Identifier (NPI) is 1851334759, issued by NPPES.
Does Dr. Neeraj Sharma accept Medicare assignment?
Yes. Dr. Neeraj Sharma accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Neeraj Sharma commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.